Press release
Diffuse Large B-cell Lymphoma Therapeutics Market 2024-2033: Trends, Growth & Analysis
The diffuse large b-cell lymphoma therapeutics market size is expected to see strong growth in the next few years. It will grow to $6.49 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to biomarker discovery, immunotherapy advancements, rising incidence rates, global aging population, healthcare infrastructure development, expanded access to novel drugs.. Major trends in the forecast period include rise of outpatient treatment settings, collaborative clinical trials, patient-centric care models, advances in diagnostic imaging, healthcare digitalization..
Market Overview -
Diffuse large B-cell lymphoma therapeutics refer to the treatment approaches and medications used to manage and combat diffuse large B-cell lymphoma, a type of non-Hodgkin lymphoma characterized by rapidly growing cancerous B-cells.
Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=10805&type=smp
Rising Prevalence Of Diffuse Large B-Cell Lymphoma To Drive Market Growth
The increasing incidence of diffuse large B-cell lymphoma (DLBCL) is expected to propel the growth of the diffuse large B-cell lymphoma therapeutics market going forward. Diffuse large B-cell lymphoma (DLBCL) is a type of aggressive cancer that originates from B-cells in the lymphatic system and is characterized by rapid and diffuse growth. It is a type of non-Hodgkin lymphoma (NHL). The diffuse large B-cell lymphoma therapeutics help to improve outcomes for individuals already diagnosed with the condition by targeting and managing the cancer cells. For instance, the American Cancer Society, a US-based voluntary health organization, estimated that in 2023, about 80,550 people (44,880 males and 35,670 females) will be diagnosed with non-Hodgkin's lymphoma (NHL), where about 20,180 people will die from NHL. Therefore, the increasing incidence of diffuse large B-cell lymphoma (DLBCL) drives the growth of the diffuse large B-cell lymphoma therapeutics market.
Competitive Landscape -
Major companies operating in the diffuse large b-cell lymphoma therapeutics market report are Novartis AG, Pfizer Inc., Merck & Co Inc., GlaxoSmithKline plc, F. Hoffmann-La Roche AG, CTI BioPharma Corp., Celltrion Healthcare Co Ltd., Bristol-Myers Squibb Company, AbbVie Inc., Gilead Sciences Inc., Seagen Inc., Kite Pharma Inc., ADC Therapeutics SA, Bayer AG, Erytech Pharma SA, Xencor Inc., Denovo Biopharma LLC, Calithera Biosciences Inc., IMV Inc., Biogen Inc., Autolus Therapeutics plc, Allogene Therapeutics Inc., Spectrum Pharmaceuticals Inc., AstraZeneca PLC, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Aptevo Therapeutics Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson, Celgene Corporation, Eli Lilly and Company, Sanofi SA, Seattle Genetics Inc., Karyopharm Therapeutics Inc., TG Therapeutics Inc., MorphoSys AG,
Advancements In Drug Therapeutics Transforming The Market
Development drug therapeutics are a key trend gaining popularity in the diffuse large B-cell lymphoma therapeutics market. Major companies operating in the diffuse large B-cell lymphoma therapeutics market are developing drugs for therapies to sustain their position in the market. For instance, in June 2022, Bristol-Myers Squibb, a US-based pharmaceutical company focused on research and development of drugs, received US FDA approval for CAR T Cell Therapy Breyanzi for the treatment of patients with diffuse large B-cell lymphoma (DLBCL), large B-cell lymphoma (LBCL), and relapsed or refractory large B-cell lymphoma. Breyanzi is a CD19-directed chimeric antigen receptor (CAR) T-cell therapy for a broad range of patients having primary mediastinal large B-cell lymphoma, high-grade B-cell lymphoma, and follicular lymphoma grade 3B.
Browse Full Report @
https://www.thebusinessresearchcompany.com/report/diffuse-large-b-cell-lymphoma-therapeutics-global-market-report
Key Segments -
The diffuse large b-cell lymphoma therapeutics market covered in this report is segmented -
1) By Drug Class: Cisplatin, Carboplatin, 5-fluorouracil, Docetaxel, Paclitaxel, Methotrexate, Other Drugs
2) By Therapy: Targeted Therapy, Immunotherapy, Chemotherapy, Other Therapies
3) By Route of Administration: Oral, Parenteral, Other Routes
4) By End User: Hospitals, Clinics, Other End-Users
Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diffuse Large B-cell Lymphoma Therapeutics Market 2024-2033: Trends, Growth & Analysis here
News-ID: 3477736 • Views: …
More Releases from The Business research company
Exploring the Global Electric Motors Market: A Comprehensive Overview
The electric motors market size has grown steadily in recent years. It will grow from $103.21 billion in 2023 to $107.6 billion in 2024 at a compound annual growth rate (CAGR) of 4.3%. The growth in the historic period can be attributed to industrial revolution, electrification of industries, transportation and automotive industry, consumer appliances and home automation.
The electric motors market size is expected to see steady growth in…
Gaming Galore: Digital PC Games Transform Entertainment by 2024- Discusses how d …
The digital pc games market size has grown rapidly in recent years. It will grow from $11.99 billion in 2023 to $13.63 billion in 2024 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to digital distribution platforms, internet connectivity, convenience and accessibility, regular updates and patches.
The digital pc games market size is expected to see rapid growth in…
Precision Tools, Powerful Outcomes: Cutting Tool Innovations Thrive in 2024- Hig …
The cutting tool and machine tool accessory market size has grown strongly in recent years. It will grow from $72.27 billion in 2023 to $78.4 billion in 2024 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to manufacturing industry growth, automotive and aerospace manufacturing, tool wear and replacement, tooling efficiency and precision,.
The cutting tool and machine tool accessory…
Precision Tools, Powerful Outcomes: Cutting Tool Innovations Thrive in 2024- Hig …
The cutting tool and machine tool accessory market size has grown strongly in recent years. It will grow from $72.27 billion in 2023 to $78.4 billion in 2024 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to manufacturing industry growth, automotive and aerospace manufacturing, tool wear and replacement, tooling efficiency and precision,.
The cutting tool and machine tool accessory…
More Releases for Therapeutics
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
Pruritus Drug Market – Key Players are Cara Therapeutics, Enteris BioPharma, N …
The Pruritus Drug Market research report is a significant investigation of changing business sector elements, driving elements, impediments, and limitations that have been considered the most extensive impacts on market development. Adroit investigative devices, for example, Porter’s Five Forces examination, SWOT examination, and Feasibility examination study have likewise been utilized by the report to offer an exhaustive information of the market. It will go about as a key research report…
Dravet Syndrome Therapeutics- Pipeline Analysis 2018 | Zogenix, Inc., Ovid Thera …
Dravet syndrome is a form of severe myoclonic epilepsy that occurs in infants during their first year of age. If left untreated, it can be associated with other types of seizures, and status epilepticus. Children having Dravet syndrome are generally observed with poor cognitive skills and hyperactivity.
Download the sample report @ https://www.pharmaproff.com/request-sample/1098
It severely affects the person’s quality of life and around 10-20% of the patient are estimated to die due…
Global mRNA Cancer Vaccines and Therapeutics Market to 2025| Moderna Therapeutic …
Researchmoz added Most up-to-date research on "Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2019-2025" to its huge collection of research reports.
mRNA Cancer Vaccines and Therapeutics Market report includes (6 Year Forecast 2019-2025) includes Overview, classification, industry value, price, cost and gross profit. It also offers in-intensity insight of the mRNA Cancer Vaccines and Therapeutics industry masking all vital parameters along with, Drivers, Market Trends, Market Dynamics,…
Global Pruritus Therapeutics Market Report 2019 Companies included Actavis, Trev …
Market Reports Company has recently published 7th edition of Pruritus Therapeutics Market Report which covers historic data of year 2013 to 2018 along with a forecast till year 2026.
For inquiry or free sample pages email us at: sales@marketreportscompany.com
The report provides a comprehensive view on the current state and future prospects of the market which analyzes different strategies for business growth. The global Pruritus Therapeutics market was valued at USD xx…
MRNA Vaccines & Therapeutics Market 2019 Global Analysis By Key Players – Mode …
WiseGuyReports.Com Publish a New Market Research Report On –“ MRNA Vaccines & Therapeutics Market 2019 Global Analysis By Key Players – Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics”.
Description:-
The mRNA Vaccines & Therapeutics industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, mRNA Vaccines & Therapeutics market size to maintain the average annual growth rate of XXX from…
